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Vitamin A and its metabolite, retinoic acid (RA) are
implicated in the regulation of immune homeostasis
via the peripheral induction of regulatory T cells.
Here we showed RA was also required to elicit proin-
flammatory CD4+ helper T cell responses to infection
and mucosal vaccination. Retinoic acid receptor
alpha (RARa) was the critical mediator of these
effects. Antagonism of RAR signaling and deficiency
in RARa (Rara/) resulted in a cell-autonomous
CD4+ T cell activation defect, which impaired inter-
mediate signalingevents, includingcalciummobiliza-
tion. Altogether, these findings reveal a fundamental
role for the RA-RARa axis in the development of
both regulatory and inflammatory arms of adaptive
immunity and establish nutritional status as a broad
regulator of adaptive T cell responses.
INTRODUCTION
A growing body of literature suggests that nutrient status and
metabolism can strongly influence the initiation, homing
capacity, and polarity of CD4+ T cell responses (Fox et al.,
2005). For instance, retinoic acid (RA), a vitamin A metabolite,
was shown to upregulate the mucosal homing receptors CCR9
and integrin alpha4beta7 (a4b7) on activated T and B lympho-
cytes (Iwata et al., 2004; Mora et al., 2006). We and others also
previously showed that RA from dendritic cells (DCs) andmacro-
phages in the gut and associated lymphoid tissues (GALTs) can
synergize with transforming growth factor beta (TGF-b) to induce
Foxp3 in CD4+ T cells stimulated in vitro, endowing them with
features that mimic thymic-derived Foxp3+ T regulatory (Treg)
cells (Coombes et al., 2007; Denning et al., 2007; Elias et al.,
2008; Mucida et al., 2007; Sun et al., 2007). Owing to the
capacity of GALT antigen-presenting cells (APCs) to synthesize
RA, vitamin A metabolism has been posited to facilitate oral-antigen-induced Treg cell induction in vivo (Coombes et al.,
2007; Mucida et al., 2005; Sun et al., 2007). Conversely, RA
inhibits production of T helper type 17 (Th17) cells induced by
IL-6 and TGF-b (Elias et al., 2008; Mucida et al., 2007). Reinforc-
ing the perception that RA is anti-inflammatory is that RA in
concert with TGF-b also inhibits the capacity of effector and/or
memory CD4+ T cell to produce cytokine (Hill et al., 2008). Over-
all, the regulatory aspects of RA in vitro fit with the paradigm
of mucosal tissues as hyporesponsive environments during
steady-state conditions (Elias et al., 2008; Hill et al., 2008;
Maynard et al., 2009). However in the event of pathogenic expo-
sure, overcoming these regulatory hurdles is essential, and how
RA is integrated into this framework is unclear.
Vitamin A insufficiency affects 250 million people worldwide
and increases the likelihood of childhood mortality to common
lung and gastrointestinal infection (Sommer, 2008; Underwood,
2004). Although enhanced susceptibility to such infections
has been attributed, in part, to impaired epithelial barrier protec-
tion (Biesalski and Nohr, 2004; Stephensen, 2001), immunolog-
ical defects may also underlie dysregulated responses to
mucosal pathogenswhen vitamin A stores are low. In this regard,
studies have suggested that vitamin A metabolites support the
differentiation and functional maturation of innate immune cells
(Cerwenka et al., 2000; Lawson and Berliner, 1999; Stephensen,
2001). However, it is still unclear how vitamin A metabolites
contribute to T cell activation in vivo during infection and
immunization.
To date, the in situ regulation of mucosal CD4+ T cell
responses via retinoids during infection or inflammation has
not been investigated. Gaining an understanding of the metabo-
lites that control vitamin A dependent immunity and the relevant
signaling pathways involved is critical to resolving the paradox of
why retinoids are immunosuppressive in some contexts, yet
vital for host protective immunity. In this study, we demonstrated
that RA was central for the induction of effector CD4+ T cell
responses during infection and vaccination. We showed a cell-
intrinsic involvement of the RA receptor, RARa, in T cell activa-
tion and identified a heretofore-unappreciated role for the RA-
RARa axis in driving T cell immunity. Combinedwith our previousImmunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc. 435
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Figure 1. Vitamin A Metabolite-Dependent Signaling Is Sustained and Systemic during T. Gondii Infection
(A) C57BL/6mice were infected orally with ten bradyzoite cysts of ME-49 clone C1. On day 8 postinfection (p.i.), single-cell suspensions prepared from the spleen
(Sp), mesenteric lymph nodes (mln), and small intestinal lamina propria (Lp) were stained with fluorochrome-labeled antibodies and assessed for a4b7 and T-bet
expression by flow cytometry. Dot plots are gated on Foxp3–CD44hiCD62Llo CD4+ T cells and representative of three mice per group.
(B) C57BL/6 mice were infected intraperitoneally with ten bradyzoite cysts of ME-49 clone C1. On day 8 p.i., single-cell suspensions prepared from the spleen
were stained and assessed as described in a4b7 and T-bet expression.
(C) Ctl and VAI mice were infected orally with T. gondii. On day 8, single-cell suspensions were stained for a4b7. Bar graphs summarize the average frequency of
Foxp3– CD44hi CD4+ T cells expressing a4b7; n = 3–4 mice per group.
(D) Ctl and VAI mice were infected intraperitoneally with T. gondii and assessed as described in (C). n = 6–8 mice. For (C) and (D), error bars illustrate the standard
deviation (SD). Statistical comparisons were performed with the unpaired Student’s t test ***p < 0.001, ns = not significant. Results are representative of three
independent experiments.
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Role of Vitamin A Metabolite Signaling in Immunityfindings, we propose that this axis mediates both regulatory and
inflammatory circuits of the immune response.
RESULTS
Retinoic Acid-Mediated Signaling Occurs during
Systemic Inflammation
To begin to address the paradoxical effects of vitamin A meta-
bolites in immunity, we evaluated the expression of signature
homing markers influenced by RA during oral infection with
Toxoplasma gondii (T. gondii). This parasite induces a strong
inflammation and a robust systemic Th1 cell response (Gazzinelli
et al., 1992; Suzuki et al., 1988). We inoculated mice with ten
cysts of the type II avirulent T. gondii strain ME-49 and examined
CD4+ T cells, which are the dominant responding T cell subset
during the acute stage of infection. Accordingly, a large propor-
tion of activated cells within the small intestinal lamina propria
(Lp), the draining mesenteric lymph nodes (mln), and spleen436 Immunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc.(Sp) expressed the transcription factor T-bet, which mediates
interferon gamma (IFN-g) production (Figure 1A). Expression of
themucosal homingmolecules a4b7 andCCR9, indicative of ret-
inoic acid signaling (Iwata et al., 2004; Svensson et al., 2008),
were also observed on a proportion of activated CD4+ T cells
in each of these tissues (Figure 1A and data not shown).
Unexpectedly, expression of thesemarkers wasmainly confined
to T-bet+ cells (Figure 1A). To determine whether a4b7 induction
was unique to the oral route of infection with T. gondii, we inoc-
ulated animals intraperitoneally (i.p.), and noted again a large
proportion of activated CD4+ T cells expressing a4b7, most of
which coexpressed T-bet (Figure 1B). These results suggested
that RA signaling is sustained and occurs systemically during
inflammatory responses.
An alternate possibility is that signaling molecules, other than
retinoic acid, contributed to a4b7 expression in response to
infection. To address this, we employed a natural model of
vitamin A insufficiency (VAI) in which mice no longer received
Immunity
Role of Vitamin A Metabolite Signaling in Immunityvitamin A in their diet starting day 14.5 in utero (Smith et al.,
1987). At 10 weeks of age, these mice, which displayed normal
gut histology and thymic T cell development (data not shown),
were deficient in vitamin A and its derivative metabolites as
evidenced by diminished a4b7 expression on CD44hi CD4+
T cells (Figure S1 available online). Eight days after infection
with T. gondii, a4b7 remained virtually absent on activated
CD4+ T cells in VAI mice, strongly suggesting that its upregula-
tion was strictly dependent on RA during both steady-state
and inflammatory conditions (Figures 1C and 1D). Thus, RA
signaling is sustained during infection and exerts a systemic
influence on CD4+ T cells regardless of the route of infection,
indicating that vitamin A metabolism may imprint features that
exceed homing potential during infection.
Mucosal and Systemic CD4+ T Cell Immunity Is Impaired
in the Absence of Vitamin A Metabolites
To explore the impact of vitamin A insufficiency during infection,
we examined the acute-phase Th1 cell response in VAI mice
after oral inoculation with T. gondii. To this end, we measured
IFN-g in supernatants upon in vitro restimulation of T cells with
soluble T. gondii antigen (STAg). T cells enriched from the mln,
Lp, as well as the Sp of infected VAI mice produced significantly
less IFN-g than control counterparts upon recall (Figure 2A). The
reduction in Th1 responsiveness was reflected in the enhanced
parasite burden observed both systemically (Sp) and in the Lp
of VAI mice (Figure 2B). IP infection with T. gondii yielded similar
findings, in which, CD4+ T cells removed from VAI animals and
rechallenged with STAg produced less IFN-g on a per cell basis
(mean fluorescence intensity, MFI = 1800 ± 380 in VAI versus
5300 ± 870 for Ctl, p < 0.003; n = 3 mice/group). We also noted
enhanced parasite burdens in the peritoneal exudates (Pecs)
and Sp of these animals (Figure 2C), emphasizing that impaired
Th1 cell immunity to T. gondii during vitamin A insufficiency is not
solely a consequence of defective responsiveness in the GALT.
These data suggest a role for vitamin A metabolites in the
capacity of CD4+ T cells to acquire effector function during
infection.
T. gondii is able to infect all nucleated cells and regulates
adaptive immunity through multiple pathways. Therefore, we
also assessed the influence of vitamin Ametabolism on mucosal
immunity in a noninfectious system with a model antigen. We
orally vaccinated mice with a mixture of OVA and the mucosal
adjuvant, LT (R129G), a nontoxic mutant of the heat-labile
enterotoxin of Eschericia coli. This regimen induces a Th1 and
robust Th17 cell response (Hall et al., 2008); the latter is distin-
guished by expression of the transcription factor, RORg(t), in
T cells and production of interlukin-17 (IL-17) (Ivanov et al.,
2006). After two rounds of vaccination, we detected abundant
IFN-g and IL-17 in the supernatants of in vitro restimulated Lp
and Peyer’s patch (Pp) cells from control mice, whereas less
was detected from the mln (Figure 2D). Coincident with IL-17
protein, flow cytometric analysis revealed substantial expression
of RORg(t) in Foxp3– CD4+ T cells from the Lp (44.8% ± 6.4%)
and Pp (9.3% ± 0.4%) (Figures 2E and 2F). Yet, GALT cells
from VAI mice secreted marginal amounts of IFN-g and IL-17
(Figure 2D). This reduction in IL-17 corresponded with dimin-
ished RORg(t) expression in both the Lp (13.7% ± 5.9%) and
Pp (1.7% ± 0.8%). Moreover, the frequency of CD4+ T cellsexpressing the nuclear proliferation antigen, Ki-67, was signifi-
cantly reduced, indicating decreased T cell activation and/or
proliferation in response to vaccination in VAI mice (Figures 2E
and 2F). Collectively, these results suggest that vitamin A is
critical for optimal T cell responses.
RA Restores CD4+ T Cell Immunity in the Absence
of Vitamin A
Impaired Th1 and Th17 cell responses in VAI mice could also
emerge from a developmental defect in these animals and not
reflect a genuine role for vitamin A metabolites on Th1 and Th17
cell development (Mora et al., 2008; Ziouzenkova et al., 2007).
Vitamin A metabolism produces several signaling competent
derivatives in the host. RA, in particular, has been shown
previously to induce strong effects on a variety of immune
cell populations in vitro (Geissmann et al., 2003; Mora et al.,
2008) and in vitamin A-replete settings in vivo (Mucida et al.,
2007; Xiao et al., 2008). However, the effect of RA on T cell immu-
nity in the absence of other vitamin A metabolites, which may
exert confounding influences, has never been interrogated. To
test whether RA could restore protective immunity in vivo, we
treated VAI mice with RA every other day. We then innoculated
them orally with T. gondii on day 5 of treatment. In contrast
to vehicle-treated animals, T. gondii-infected VAI mice that
received short-term RA displayed a striking recovery in ex vivo
T cell IFN-g responses to STAg, both in the Sp and Lp (Figure 3A).
Assessment of intracelular IFN-g further revealed that Lp CD4+
T cells responded as potently as their control counterparts to
antigen restimulation (Figure 3B). Importantly, this reboundculmi-
nated in functional immunity to toxoplasmosis, enhancing para-
site clearance so that parasite burdens mirrored those observed
in control-infected animals (Figures 3C and 3D). We next exam-
ined the effect of RA on Th17 cell responses via oral vaccination
with LT(R129G) and OVA. Lp Foxp3– CD4+ T cells from
RA-treated animals regained their capacity to produce IL-17, in
some instances to a degree that exceeded what was observed
in control animals (Figure 3E). This capacity was coupled to a
rebound in RORg(t) expression and markedly enhanced T cell
proliferation, as measured by intracellular Ki-67 (Figures 3E and
3F). The efficacy of short-term treatment with RA argues that
rather than a developmental deficit causing impaired CD4+
T cell immunity in VAI mice, this metabolite provides essential
signals to mediate Th1 and Th17 cell responses.
RARa Regulates CD4+ T Cell Immunity and Homeostasis
RA signals through several families of nuclear hormone recep-
tors. The best characterized are RA receptors (RAR) a, b and
g, which transcriptionally regulate gene expression in partner-
ship with retinoid X receptors (Chambon, 1996). Previously,
TGF-b was shown to induce Rara expression (Schambach
et al., 2007). We and others also showed that this receptor was
required for RA to enhance Treg cell differentiation in vitro (Hill
et al., 2008; Nolting et al., 2009). Using real-time quantitative
PCR, we observed that naive CD4+ T cells had high mRNA
expression of Rara, whereas Rarg was less expressed and
Rarb was not detectable (ND) (Figure 4). To deduce whether
RARa played a role in RA directed immunity, we orally vacci-
nated RARa-deficient (Rara/) mice with LT (R129G) and
OVA. Unlike VAI mice, which after 16 weeks begin to succumbImmunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc. 437
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Figure 2. Th1 and Th17 Cell Immune Responses Are Impaired in the Absence of Vitamin A Metabolites
(A and B) Ctl and VAI mice were infected orally with T. gondii (A) On day 8 p.i., pooled tissue suspensions were enriched for T cells and cultured with irradiated
BMDC ± soluble T. gondii antigen (STAg) for 48 hr. IFN-g was measured in triplicate supernatants by ELISA. n = 4–5 mice per group.
(B) Parasite burdens in the spleen (Sp) and small intestinal lamina propria (Lp) of individual mice were determined by plaque assay. Results are expressed as
plaque forming units (PFUs). Each dot represents an individual mouse.
(C) Ctl and VAI mice were infected intraperitoneally with T. gondii. Parasite burden was assessed day 8 p.i.; n = 6–8 mice per group.
(D–F) Ctl and VAI mice were immunized orally with a mixture of OVA and themutant E. coli labile toxin, LT(R129G), once per week. On day 14, pooled cell suspen-
sions frommesenteric lymph nodes, Peyer’s patches (Pp) and small intestinal lamina propria were cultured with BMDCs uninfected or infected with recombinant
vaccinia virus expressing OVA (iDCs) for 72 hr. Supernatant triplicates were assayed for IFN-g and IL-17 by ELISA. n = 3–4 mice per group.
(E and F) Small intestinal lamina propria (E) and Peyer’s patches (F) suspensions from individual mice were assessed for intracellular RORg(t) and Ki-67 by flow
cytometry. Representative dot plots from small intestinal lamina propria and Peyer’s patches of WT and VAI mice gated on viable Foxp3– CD4+ T cells are shown.
Bar graphs summarize the frequency of Ki-67+ and RORg(t)+. Error bars in (A) and (D) depict the standard error of the mean (SEM); error bars in (E) and (F) depict
the SD. *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 3. Retinoic Acid Is Required for CD4+
T Cell Immunity
(A–C) Ctl and VAI mice treated with RA or vehicle
were infected orally with T. gondii and evaluated
on day 8 p.i. n = 3 mice per group.
(A) Pooled cell suspensions from the spleen (Sp) or
small intestinal lamina propria (Lp) were enriched
for T cells and cultured with irradiated BMDC ±
STAg for 48 hr. Bar graphs present the average
amount of IFN-g in duplicate or triplicate superna-
tants.
(B) Small intestinal lamina propria samples were
incubated for 14 hr with STAg and analyzed for
intracellular IFN-g via flow cytometry. Stacked
histograms are gated on viable, Foxp3– CD4+
T cells.
(C) Parasite burden in the spleen and small
intestinal lamina propria of individual mice was
measured by PFU.
(D) Visualization of parasite localization in du-
odenal-jejunal sections of individual mice orally
infected with T. gondii on day 9 p.i.
(E and F) Ctl and VAI mice treated with RA or
vehicle were immunized orally with a mixture of
OVA and LT(R129G) on day 0 and 4. n = 3 mice
per group.
(E) On day 7, suspensions pooled from small intes-
tinal lamina propria were enriched for T cells and
cultured with SpDC ± OVA for 14 hr and examined
for intracellular IL-17 and IFN-g. Contour plots are
gated on viable, Foxp3– CD4+ T cells.
(F) Small intestinal lamina propria cells from
individual mice were analyzed for intracellular
RORg(t) and Ki-67 by flow cytometry. Bar graphs
depict Ki-67 and RORgt as a frequency of
Foxp3– CD4+ T cells.
(A–F), RA-treated groups received 250 mg RA
intraperitoneally 5 days prior to infection or
vaccine and every other day thence until take-
down. Error bars in (A) depict the SEM. Error
bars in (C) and (F) depict the SD. *p < 0.05; **p <
0.01; ***p < 0.001; ns, not significant. Results are
representative of two (E and F) or three (A–D) inde-
pendent experiments.
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Role of Vitamin A Metabolite Signaling in Immunityto a wasting disease, these animals displayed no overt impair-
ments as adults (Lufkin et al., 1993). Notably, this vaccine
regimen did not induce an antigen-specific Th17 cell response
in mice on this mixed 129 background (data not shown). Never-
theless, relative to wild-type (WT) littermates, CD4+ T cells from
Rara/ mice expressed attenuated amounts of the Th1 cell-
driving transcription factor T-bet after vaccination and secreted
virtually no IFN-g upon antigen recall (data not shown and
Figure 4B). Thus, abrogation of RARa impaired CD4+ T cell
immunity.
It has been shown that RAR antagonism inhibits mucosal
DC-induced Treg cell generation in vitro (Coombes et al.,
2007; Mucida et al., 2007; Sun et al., 2007). Consistent with
this finding, Treg cell induction in response to antigen feeding
was abrogated in VAI mice (Figures S2A–S2C). Nevertheless,
thymic Treg cell differentiation was intact in these animals, asit was in Rara/ mice (Figures 2D and 2E and data not shown).
Paradoxically, however, we observed an increase in the
frequency of Treg cells within the Lp of VAI mice (Figure 4C).
As described previously, we noted a similar increase in the Lp
of Rara/ mice (Hill et al., 2008). Thus, despite the impairment
in GALT Treg cell induction, loss of RA or RARa-mediated
signaling led to an increase in the frequency of Lp Treg cells.
On the basis of their potential to raise the threshold of immune
activation (Hall et al., 2008), we assessed whether the relative
increase in the frequency of Lp Treg cells contributed to
impaired CD4+ T cell responses. We established VAI DEREG
mice (Lahl et al., 2007), in which Treg cells could be selectively
depleted upon injection of diphtheria toxin (DT). Oral vaccination
in conjunction with DT treatment readily depleted Treg cells and
restored Foxp3 CD4+ T cell proliferation in the Lp (Figure 4D).
However, Th1 and Th17 cells remained undetectable in VAIImmunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc. 439
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Figure 4. The RA-RARa Signaling Axis Regulates CD4+ T Cell Immunity and Homeostasis
(A) mRNA from sort-purified naive CD4+ T cells (Foxp3– CD25– CD44lo) was assessed for Rara, Rarb, and Rarg via quantitative RT-PCR and normalized to the
housekeeping gene hypoxanthine phosphoribosyltransferase 1. ND, not detected.
(B) Rara/ and littermate control WTmice were immunized orally with a mixture of OVA and themutant E. coli labile toxin, LT(R129G), once per week. On day 21,
suspensions pooled from the spleen were enriched for T cells and cultured with BMDC uninfected or infected with recombinant vaccinia virus expressing OVA
(iDCs) for 72 hr. IFN-g was quantified in triplicate supernatants. Results are representative of two independent experiments.
(C) Small intestinal lamina propria (Lp) cell suspensions from VAI, Rara/ and their respective control counterparts were assessed for Foxp3+ Treg via flow
cytometry. Results are expressed as a proportion of viable TCRb+ CD4+ T cells.
(D and E) Ctl, VAI, and VAI DEREGmice immunized orally with a mixture of OVA and LT(R129G) on days 0 and 4 were treated with 1 mg of diphtheria toxin 72 and
24 hr prior to vaccination and every subsequent 48 hr through termination of experiment.
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Role of Vitamin A Metabolite Signaling in Immunitymice after this treatment (Figure 4E). These data suggest that
impaired immune responses upon loss of vitamin A-dependent
signaling are not caused by an enhanced frequency of Treg
cells.
The increase in the frequency of Lp Treg cells revealed that
GALT T cell homeostasis was perturbed in both Rara/ and
VAI mice. Quantification of CD4+ T cell subsets indicated that
in both these animals, the increase in Lp Treg frequency was
due to a 2- to 4-fold selective reduction in the number of
Foxp3– CD4+ T cells within the Lp (Figure 4F). Importantly, treat-
ing VAI mice with RA during T. gondii infection and vaccination
restored GALT T cell equilibrium in addition to T helper cell
responses (Figure 4G). These findings demonstrate that defi-
ciency in RARa alone can recapitulate the effects of vitamin A
insufficiency on T cell homeostasis.
RARa Regulates T Cell Activation
RA-mediated enhancement of protective immunity could involve
multiple cellular targets. For example, we recently demonstrated
that RA exerted adjuvant effects on DCs upon stimulation with
IL-15 to promote adverse responses to dietary antigen (Depaolo
et al., 2011). We also observed a specific reduction in IL-6
production by LpDC from VAI mice, while other proinflammatory
mediators, such as TNF-a and IL-12 and IL-23p40 remained
intact (Figures S2F and S2G). However, expression of Rara in
naive CD4+ T cells, combined with impaired T helper immunity
in Rara/mice, also suggested a potential cell-intrinsic require-
ment for this receptor in T cell responses. To pursue this possi-
bility, we stimulated naive WT or Rara/ CD4+ CD62Lhi T cells
under Th1 and Th17 cell-polarizing conditions, in vitro, with an
APC-free system. After 48 hr in culture, relative to WT T cells,
we detected significant reductions of IFN-g and IL-17 in super-
natants from Th1 and Th17-polarized Rara/ T cells (Figure 5A).
However, these cultures contained significantly fewer cells than
WT cultures (data not shown), indicating that differences in cyto-
kine amounts were secondary to impaired cell proliferation.
Underscoring this, T cells lacking RARa proliferated
less efficiently than their WT counterparts upon polyclonal
T cell receptor (TCR) activation with anti-CD3 (Figure 5B and
Table 1). This defect persisted in the presence of costimulation
and with exogenous IL-2 (IV), suggesting that the loss of RARa
may cause an activation and or survival defect. Nevertheless,
the cells that had undergone proliferation were as capable as
WT T cells to produce IFN-g and IL-17 during Th1 and Th17
cell polarization, respectively (Figure S3). In regard to activation,
after 16 hr of stimulation, there was less upregulation of the acti-
vation markers CD69, CD25, and the iron transferrin receptor
CD71 on Rara/ T cells (Figure 5C). Given that the expression
of CD71was recently shown to depend on themammalian target
of rapamycin kinase (mTOR) activation (Zheng et al., 2007), an(D) On day 7, small intestinal lamina propria suspensions from individual mice wer
on CD4+ T cells. Each dot represents an individual mouse.
(E) Suspensions pooled from the small intestinal lamina propria were enriched fo
intracellular IL-17 and IFN-g via flow cytometry. Contour plots are gated on viab
(F) Summary of the absolute number of Foxp3+ and Foxp3– CD4+ T cells in the s
(G) Vehicle or RA-treated mice were orally infected with T. gondii or vaccinated a
propria Treg cells ± SD as a proportion of viable CD4+ T cells is shown. n = 3mice
and (B) depict the SEM. **p < 0.01; ***p < 0.001; ns, not significant.essential promoter of cell growth via protein translation (Wulls-
chleger et al., 2006), we measured the phosphorylation of the
ribosomal protein S6 (pS6), a downstream target of the mTOR
complex 1 (mTORC1), as a readout for mTOR activity. In accord
with decreased CD71, pS6 was significantly diminished in these
cells (Figure 5D). To further evaluate the effects of RA-RARa on
mTOR activation, we examined phosphorylation of AKT on
S473, a target of the mTOR complex 2 (mTORC2) in T cells
(Zhang et al., 2011). We observed decreased phosphorylation
of AKT S473 (Figure 5E). Together, these findings suggest that
impaired immune responses in the absence of RA-RARa signals
directly affect T cell activation.
TCR engagement results in the activation of multiple signaling
pathways, which promote naive T cell transition into effector
T cells. To determine whether RARa imposes global effects on
TCR pathways, we assessed proximal activation events after
anti-CD3 crosslinking. Phosphorylation of the Syk family protein
tyrosine kinase member ZAP70 (Iwashima et al., 1994) and the
transmembrane adaptor protein LAT (Zhang et al., 2000) were
similar in the absence of RARa compared toWTT cells (Figure 6A
and data not shown), suggesting that proximal TCR signaling
remained intact.
Phosphorylation of LAT induces the recruitment and stabiliza-
tion of a signaling complex comprisingmultiple critical mediators
of TCR signal transduction, including phospholipase C gamma-1
(PLCg1) (Balagopalan et al., 2010). PLCg1 catalyzes hydrolysis
of the membrane phospholipid phosphatidylinositol 4,5-biphos-
phate into inositol triphosphate (IP3), required for Ca
2+ mobiliza-
tion, and diacylglycerol (DAG). DAG contributes to activation of
the Ras-Raf-ERK pathway. Phosphorylation of PLC-g1 was
reduced in Rara/ CD4+ T cells (Figure 6B). Consistent with
this observation, we noted reduced phosphorylation of the
mitogen-activated protein kinases ERK1 and ERK2 (Figure 6B).
Although we observed variability in the degree to which the acti-
vation of these proteins was reduced between experiments,
defective signaling was a common feature of Rara/ CD4+
T cells.
In line with impaired PLC-g1 phosphorylation, Ca2+ mobiliza-
tion was dramatically reduced in Rara/ CD4+ T cells relative
to WT counterparts upon anti-CD3 crosslinking (Figure 6C).
Because RA and its metabolic precursors are constitutively
present in serum (Kane et al., 2008a; Kane et al., 2008b), we
could not exclude the possibility that deficiency in RARa resulted
in a long-lasting metabolic defect that also impairs T cell activa-
tion. As such, we also incubated WT cells with the pan-RAR
antagonist LE540 prior to T cell activation. Treatment with this
antagonist recapitulated the Rara/ phenotype, manifesting
in impaired Ca2+ mobilization upon anti-CD3 crosslinking
(Figure 6D). Supporting the idea that RARa exerts a function
downstream of the TCR-CD3 complex, Ca2+ mobilization wase assessed for intracellular Foxp3 and Ki-67 by flow cytometry. Data are gated
r T cells and cultured with purified SpDC ± OVA for 14 hr, then assessed for
le Foxp3– CD4+ T cells. n = 3–4 mice per group.
mall intestinal lamina propria of mice.
s described in Figure 3. A summary of the frequency of small intestinal lamina
per group. Data are representative of two to three experiments. Error bars in (A)
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Figure 5. Role of RARa Signaling for T Cell
Activation
(A) CD4+ CD62Lhi T cells purified from the spleen
and lymph nodes of Rara/ and littermate WT
mice were activated with plate-bound a-CD3 +
soluble a-CD28, in Th1 or Th17 cell-polarizing
conditions for 48 hr. IFN-g and IL-17 ± SEM in
culture supernatants were measured by ELISA.
***p < 0.001.
(B) CD4+ T cells were plated for 48 hr in the
following conditions: I. unstimulated, II. a-CD3,
III. a-CD3 + a-CD28, and IV. a-CD3 + a-CD28 +
IL-2. After 48 hr, cells were rested overnight in
IL-2 and assayed for CFSE intensity by flow cyto-
metric analysis. Histograms are gated on viable
CD4+ T cells.
(C and D) CD4+ CD62Lhi T cells were isolated and
activated for 16 hr.
(C) Assessment of CD69, CD25, and CD71.
Shaded histograms, unstimulated; black lines,
stimulated with a-CD3 + a-CD28 + IL-2. Numbers
indicate the mean fluorescence intensity.
(D) Assessment of phosphorylated ribosomal
protein S6 (pS6) in the following: I. unstimulated,
II. a-CD3, and III. a-CD3 + a-CD28 + IL-2 condi-
tions.
(E) CD4+ T cells (5 3 106) were stimulated with
plate-bound a-CD3 (2 mg/ml) and/or a-CD28
(10 mg/ml) for the indicated times and then lysed.
Total cell lysates were immunoblotted for phos-
phorylated (Ser473) and total Akt.
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Table 1. Impaired Proliferation of Rara–/– T Cells upon Activation
Percentage
of Cell Divided Wild-Type Rara/
Proliferation
Index Wild-Type Rara/
II 51 8 II 2.2 1.5
III 74.8 15.8 III 3.4 2.1
IV 76.4 15.4 IV 3.5 2.2
The percent of cells that underwent proliferation and calculated prolifer-
ation index are indicated.
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phore, ionomycin (Figure 6E). These findings imply that transient
blockade of RARa signaling is sufficient to impede signal trans-
duction events upon TCR recognition. Together, these data
reveal an unexpected role for RARa in regulating signaling path-
ways downstream of TCR engagement.
DISCUSSION
Although insufficient stores of vitamin A have long been linked to
impaired immunity to pathogens, the role of vitamin A metabo-
lism in the regulation of CD4+ T cell responses remains poorly
understood. In our current study, we reveal that the retinoic
acid-RARa signaling axis is essential for CD4+ T cell immunity.
Specifically, we demonstrate that mucosal Th1 and Th17 cell
responses to oral infection and vaccination are compromised
upon loss of vitamin A. These impairments are not manifesta-
tions of a developmental defect propagated upon loss of vitamin
A, given that RA rapidly restored mucosal Th1 and Th17 cell
responses. This finding indicates that this metabolite is the
cardinal mediator of vitamin A-dependent immunity in vivo.
Genetic ablation of Rara is sufficient to recapitulate the pheno-
type of VAI mice, both at steady state and during infection.
Furthermore, T cells lacking RARa or subjected to RA receptor
antagonism display early TCR activation defects and proliferate
less efficiently in response to T cell stimulation. Thus, the RA-
RARa axis broadly controls the fate of T cell immunity, at least
in part, via cell-autonomous effects on CD4+ T cells.
Although RA has been proposed to serve as a switch factor in
the induction of regulatory versus inflammatory T cells, the
importance of RA-RARa in early T cell activation events suggests
that this axis is required for Treg as well as Th1 and Th17 cell
responses. The majority of CD4+ T cells that displayed an RA
signature (based on a4b7), coexpressed T-bet. Further, in vivo
add-back experiments demonstrated that RA was capable of
restoring Th1 cell responses in VAI mice. Previous reports have
suggested that RA negatively regulates Th1 cell inflammation
(Cui et al., 2000). For instance, VAI mice produced abnormally
high amounts of IFN-g during infection with the nematode
Trichinella spiralis and failed to elicit a proper and robust Th2
cell response (Carman et al., 1992). In this system, addition of
RA to in vitro-restimulated cell suspensions decreased IFN-g
production (Cantorna et al., 1994). Although this finding could
argue that RA suppresses Th1 responses, cells in this culture
were likely of a heterogeneous activation status. In this regard,
RA was shown to be able to inhibit effector and/or memory
T cell cytokine production (Hill et al., 2008). Integrating these
data suggests that RA signaling is potentially biphasic—drivingT cell activation and/or differentiation during the early stages of
an immune response, but regulating the amplitude of effector
responses at later stages. This could be a particularly effective
strategy to allow proper initiation of immune responses while
minimizing tissue damage.
We found that diminished vitamin A prevented the acquisition
of a robust Th17 cell response in vivo. The ability of RA to restore
Th17 cell responses in VAI mice initially appears discordant with
other studies that have reported negative effects of RA on IL-17
production in vitro (Elias et al., 2008; Mucida et al., 2007) and in
certain animal models of autoimmune disease (Xiao et al., 2008).
However, in systems that have scrutinized the effects of RA at
low doses (Wang et al., 2010), and in conjunction with microbial
stimuli, such as TLR5 ligands (Uematsu et al., 2008), Th17 cell
generation was shown to be unaffected or enhanced, respec-
tively. Thus, in physiological settings and microbial rich environ-
ments, RA can potentially amplify the inflammatory tone of the
mucosal environment. Lending further support for a role of RA
in the generation of Th17 cells, several recent studies showed
that Th17 cells were virtually ablated in the Pp and Lp of VAI
mice during steady state (Cha et al., 2010; Wang et al., 2010).
In one of these studies, the deficit in Th17 was noted in young
mice on a vitamin A-deficient diet, before the defect in T cell-
homing capacity to mucosal sites should have set in (Cha
et al., 2010). Taken together, our findings show that physiological
concentrations of retinoids appear to sustain Th17 cell develop-
ment and maintenance.
Rara/mice complemented VAI mice onmultiple levels. First,
the number of Lp effector T cells was significantly reduced in
both animals compared to their control counterparts. These find-
ings suggest that during homeostatic activation, RA-RARa
signaling is critical for the upregulation of homing receptors.
Remarkably, transient treatment with RA restored both T cell
equilibrium and the CD4+ T cell response within the Lp of VAI
mice upon challenge. Because RA restored both of these param-
eters, it is difficult to dissect the contribution of homing versus
activation to the rescue of immune responses in this tissue.
However, despite defects in gastrointestinal homing, VAI mice
that were infected systemically with T. gondii also mounted
a markedly impaired Th1 cell response. This outcome could be
the product of both direct and indirect actions of RA-RARa
signaling on T lymphocytes.
As evidence that this pathway can function directly through
T cells, we demonstrated that RARa mediates signal transduc-
tion events downstream of the TCR that govern T cell activation.
Recent findings indicate a role for nutrient metabolism in T cell
activation. For instance, vitamin D-vitamin D receptor (VDR)
signaling was shown to promote the proliferation of human
T cells in response to TCR stimulation via the induction of
PLCg (von Essen et al., 2010). The DNA-binding capacity of
VDR presumably mediates this induction via transcription.
RARa is also recognized to regulate gene expression in the
same fashion (Chambon, 1996). Because RA, as well as other
retinoids, are present in the serum and tissues of mice (Kane
et al., 2008a; Kane et al., 2008b), it is intriguing to speculate
that these compounds exert constitutive effects on the phos-
phorylation status, localization, and/or conformation of RARa
in T cells, which may in turn regulate proteins involved in T cell
signal transduction pathways. Short-term incubation (<1 hr)Immunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc. 443
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Figure 6. Loss of Basal RARa Signaling Impairs Responsiveness to TCR-CD3 Engagement
(A–C) CD4+ T cells (7 3 106) were stimulated with plate-bound a-CD3 (2 mg/ml) for the indicated times and then lysed.
(A) Total cell lysates (TCL) were immunoblotted for phosphorylated (Y493) and total ZAP-70.
(B) PLC-g1 was immunoprecipitated from TCL. Tyrosine phosphorylation was assessed by immunoblotting with 4G10. ERK1/2 activation was evaluated
from TCL.
(C–E) Ca2+ mobilization, cells are gated on total CD4+ T cells.
(C) Rara/ (gray line) and WT mice (black line).
(D and E) Vehicle-treated (black line) versus LE540 (dashed line, 2.5 mM) -treated cells. Histograms depict the median ratio of DAPI-A/Indo-1-A of Ca2+ fluxing
cells as a function of time (seconds).
(C and D) Addition of biotinylated a-CD3 (10 mg/ml) (1) and crosslinking, streptavidin (20 mg/ml) (2).
(E) Black arrow denotes addition of ionomycin (iono).
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a manner similar to that observed in Rara/ T cells. One expla-
nation for this finding is that transcriptional modification via
RARa regulates the expression or activity of a mediator of
T cell activation. Alternatively, RARa may potentially facilitate
TCR-dependent signal transduction through extranuclear
activity. For example, in a neuroblastoma cell line, RARa was
described to interact with the p85 subunit of phosphoinositide
3-kinsase in an RA-dependent manner (Masia´ et al., 2007).
Although we identify a function for RA-RARa signaling in
T cells, RARa may also affect the function of APCs, including
DCs. In human Langerhans cell-type DCs, as well as murine444 Immunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc.DCs, RARa ligands can synergize with inflammatory mediators
to enhance inflammatory potential (Geissmann et al., 2003);
(Depaolo et al., 2011). Moreover, our finding of impaired IL-6
production in LpDCs from VAI mice is consistent with the reports
of reduced Th17 cells in VAI mice during steady state (Cha et al.,
2010; Wang et al., 2010) and in response to oral vaccination. As
such, it is possible that altered APC function also contributes to
impaired adaptive immune responses in VAI and Rara/ mice.
Thus, RA-RARa signaling may converge on both innate and
adaptive arms of immunity.
In summary, the GI tract must be able to tolerate constant
exposure to food antigen and commensals and maintain the
Immunity
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conflicting pressures confront the immune system of the GI tract
with a unique challenge. One would predict that the most
judicious strategy to respond to this spectrum of recurring chal-
lenges would involve a conserved pathway that can readily
adjust to environmental cues. Here, we identified the RA-RARa
signaling pathway as fitting this mode of host control, promoting
Treg cell generation and probably tolerance during steady-state
conditions, but promoting an inflammatory response after
pathogen encounter. As such, we propose that RA regulates
adaptive immunity in a manner that is parallel to TGF-b, in which
accompanying signals dictate whether a response ultimately
becomes regulatory in nature or inflammatory (Zhou et al.,
2008). An important consideration is that adaptive immune
responses often involve multiple waves of APC recruitment.
Based on the systemic RA-mediated signals that we observe
during infection, it will be interesting to examine how newly
recruited APCs contribute to the RA-RARa signaling axis during
inflammation. Finally, the requirement of RARa for T cell activa-
tion suggests that this pathway may have evolved early with
the development of adaptive CD4+ T cell responses to coordi-
nate host protection.
EXPERIMENTAL PROCEDURES
Mice
B6.SJL (CD45.1) and OTII mice were purchased from Taconic Farms.
Foxp3eGFP and DEREG mice were bred in house. Rara/ mice were a
generous gift of P. Chambon (Chapellier et al., 2002) and obtained from
C. Benoist (HarvardMedical School). All mice were bred andmaintained under
pathogen-free conditions at an American Association for the Accreditation of
Laboratory Animal Care accredited animal facility at the NIAID and housed in
accordance with the procedures outlined in the Guide for the Care and Use of
Laboratory Animals under an animal study proposal approved by the NIAID
Animal Care and Use Committee. For each experiment, mice were gender,
aged, and/or littermate matched. All mice were used between 8 and 13 weeks
of age.
Diet Studies
Vitamin A-deficient (TD.09838) and -sufficient (20,000 IU vitamin A/kg,
TD.09839) diets were purchased from Harlan Teklad Diets. At day 14.5 of
gestation, pregnant females were administered either vitamin A-deficient or
-sufficient diet and maintained on diet until weaning of litter. Upon weaning,
females were returned to standard Harlan chow, whereas weanlings were
maintained on special diet until use. Diet was replaced in the feed hopper every
3–4 days. For breeding, females were rested on a standard Harlan chow diet
for at least 2 weeks prior to remating. After three birth cycles under the vitamin
A-deficient diet, females were retired.
Flow Cytometry
Single-cell suspensions were incubated in ice-cold HBSS with 1/100 a-mouse
CD16/32 (eBioscience), 0.2mg/ml purified Rat IgG (Jackson Immunoresearch)
and stained with fluorochrome-conjugated antibodies against any combina-
tion of the following surface antigens: TCR-b (H57-597), CD4 (RM4-5), CD8a
(53-6.7), CD25 (PC61.5), CD44 (IM7), CD62L (MEL-14), CD103 (2E7), and
a4b7 (DATK32)—for 15 min on ice. All antibodies were purchased from
eBioscience.
T Cell Phenotype
Cell suspensions were stained with 1/500 LIVE/DEAD Fixable Blue Dead cell
stain kit (Invitrogen) in tandem to exclude dead cells. For examination of tran-
scription factors and cellular proliferation, cells were subsequently treatedwith
the Foxp3 staining kit (eBioscience) in accordance with the manufacturer’s
instructions and stained for 30 min on ice with fluorochrome-conjugated anti-bodies against the following: Ki-67 (B56, BD PharMingen), Foxp3 (FJK-16 s),
T-bet (eBio4B10), and/or RORg(t) (AFKJS-9) or the following isotype controls:
mouse IgG1 (BD PharMingen) rat IgG2a (eBR2a), and mouse IgG1 (clone P3)
—in 1/100 a-mouse CD16/32 and 0.2 mg/ml purified Rat IgG. Unless indi-
cated, antibodies were purchased from eBioscience. All cell acquisition was
performed with an LSRII machine with FACSDiVa software (BD Biosciences).
Data were analyzed with FlowJo software (TreeStar). For calculating absolute
numbers, the fraction of a particular subset to singlet-gated, total living cells
was multiplied by the total cellularity of the tissue based on trypan blue
exclusion.Parasite and Infection Protocol
ME-49-expressing RFP was created as previously described (Oldenhove
et al., 2009). To obtain tissue cysts, we removed brains from C57BL/6 mice
that were inoculated with three cysts by gavage 1–2 months prior and homog-
enized in 1 ml of phosphate buffer saline (pH 7.2). Diet study mice were
infected orally with 10 cysts at 9.5–11.5 weeks of age. STAg was prepared
as previously described (Grunvald et al., 1996). To assess parasite burden,
we used human fibroblast (Hs27; ATCC no. CRL-1634) cultures as described
previously (Pfefferkorn and Pfefferkorn, 1976; Roos et al., 1994). In brief, titra-
tions of single-cell tissue suspensions (13 104 up to 13 106 cells) were added
onto confluent fibroblast monolayers cultured in DMEM supplemented with
100 mg/ml P/S and 10% FBS (in 24-well plates). Plaques were detected by
fluorescence with an Axiovert 40 inverted microscope (Zeiss) outfitted with
an RFP filter and reported as Plaque forming units (PFUs).Vaccine Protocol
For vaccination, mice were orally inoculated with an isotonic bicarbonate
buffer. Ten minutes later, mice were gavaged with a mixture of 1 mg of OVA
and 10 mg of the mutant form of E. coli LT (R129G) prepared in the same buffer.
LT(R129G) was kindly provided by J. Clements. For reconstitution experiments
with RA, mice were vaccinated again on day 4. Immune responses were then
assessed on day 8. For all other experiments, mice were vaccinated once per
week and immune responses were assessed 1 week after challenge.In Vivo RA Reconstitution
A total of 250 mg of all-trans-RA (Sigma Aldrich), resuspended in 30 ml of
biotechnology performance certified DMSO (Sigma Aldrich) was administered
intraperitoneally to vitamin A-insufficient mice every other day. Twenty-four
hours after the third injection, mice were infected with T. gondii or vaccinated.
Injection of RA continued until takedown of the mice. Mice not receiving RA
received DMSO vehicle. One-use aliquots of RA were stored at 80C in
pure DMSO in amber ependorf tubes.ELISA
Tissues were harvested from infected or vaccinated mice, pooled by group,
and enriched for T cells as described above. For T. gondii, T cells (2.5 3 105)
were incubated with irradiated day 6 BMDC (5 3 104) ± STAg (5 mg/ml) in
250 ml/well in 96-well round-bottom plates for 48 hr at 37C, 5% CO2. For
vaccine, T cells (2.5 3 105) were incubated with day 7 BMDC (5 3 104) that
had been infected or not for 12 hr with recombinant vaccinia virus expressing
OVA (MOI 10:1) for 72 hr at 37C, 5%CO2.Upon harvest of supernatants, IFN-g
and IL-17A was quantitated with the DuoSet ELISA system (R&D Systems).
In initial vaccine experiments, pooled suspensions were not T cell enriched,
but rather cultured at 5 3 105 cells to 1 3105 infected or uninfected BMDC.Ca2+ Mobilization Assay
Ca2+ flux measurements were performed as previously described (Laky and
Fowlkes, 2007). In brief, cells pooled from PLN and Sp of WT and Rara/
mice were resuspended in loading buffer (HBSS with CaCl2 and MgSO4,
10mMHEPES,and1%FBS) at adensity of 13107cells/ml in 3mMProbenecid
(Invitrogen). Onemilliliter of cells was then labeledwith 9ml of indomix contain-
ing50ml of 1mM indo-1AM+113ml ofFBS+25mlof 20%pluronic (Invitrogen)
at 30C for 40 min, then stained with cell surface markers. In a separate condi-
tion, LE540 (2.5 mM) or DMSO was added to WT cells during these steps.Immunity 34, 435–447, March 25, 2011 ª2011 Elsevier Inc. 445
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Cells were lysed in PBS containing 1% Triton X-100 and 0.05% SDS with
protease and phosphatase inhbitors. Lysates were immunoprecipitated with
the indicated antibodies and immune complexes captured with protein A
(Santa Cruz). Protein complexes were resolved on SDS-PAGE gels and trans-
ferred to nitrocellulose membranes for immunoblot analysis. Lysates were
immunoblotted with the following antibodies: anti-phosphotyrosine (4G10)
and anti-PLC-g (Millipore), anti-phospho ERK1/2, anti-ERK, anti-phospho-
Ser473Akt, anti-Akt, anti-phosphoTyr493 ZAP-70, and anti-ZAP-70 (Cell
Signaling Technology).
Statistical Analysis
Groups were compared with Prism software (GraphPad) with the unpaired
Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
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